Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents

PURPOSE: The aim was to evaluate the safety of bilateral same-day injections with intravitreal antiangiogenic drugs for macular diseases. METHODS: Cross-sectional retrospective review of unilateral and bilateral same-day antiangiogenic injections was conducted between January 2011 and March 2016 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruão, Miguel, Andreu-Fenoll, María, Dolz-Marco, Rosa, Gallego-Pinazo, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295803/
https://www.ncbi.nlm.nih.gov/pubmed/28203056
http://dx.doi.org/10.2147/OPTH.S124282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295803/
https://www.ncbi.nlm.nih.gov/pubmed/28203056
http://dx.doi.org/10.2147/OPTH.S124282

Ejemplares similares